Treatment of the Medial Meniscus With the NUsurface(R) Meniscus Implant

NCT01712191 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2023-04-06

No results posted yet for this study

Summary

This is a prospective, multi-center, open label, non-randomized study, evaluating the treating of medial meniscus deficiency with the NUsurface Meniscus Implant.

Conditions

  • Meniscus; Degeneration
  • Osteoarthritis, Knee

Interventions

DEVICE

NUsurface Meniscus Implant

Sponsors & Collaborators

  • Active Implants

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-12-31
Completion
2016-03-31

Countries

  • Belgium
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01712191 on ClinicalTrials.gov